GB201720119D0 - Prevention and/or treatment of neurodegenerative disease - Google Patents
Prevention and/or treatment of neurodegenerative diseaseInfo
- Publication number
- GB201720119D0 GB201720119D0 GBGB1720119.5A GB201720119A GB201720119D0 GB 201720119 D0 GB201720119 D0 GB 201720119D0 GB 201720119 A GB201720119 A GB 201720119A GB 201720119 D0 GB201720119 D0 GB 201720119D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- prevention
- treatment
- neurodegenerative disease
- neurodegenerative
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Marine Sciences & Fisheries (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Priority Applications (20)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1720119.5A GB201720119D0 (en) | 2017-12-04 | 2017-12-04 | Prevention and/or treatment of neurodegenerative disease |
| AU2018379644A AU2018379644B2 (en) | 2017-12-04 | 2018-05-10 | Prevention and/or treatment of neurodegenerative disease |
| EP18725605.2A EP3644979B1 (en) | 2017-12-04 | 2018-05-10 | Prevention and/or treatment of neurodegenerative disease |
| EP25186112.6A EP4599891A3 (en) | 2017-12-04 | 2018-05-10 | Prevention and/or treatment of neurodegenerative disease |
| KR1020207007980A KR20200095452A (ko) | 2017-12-04 | 2018-05-10 | 신경퇴행성 질병의 예방 및/또는 치료 |
| CA3071786A CA3071786C (en) | 2017-12-04 | 2018-05-10 | Prevention and/or treatment of neurodegenerative disease |
| PCT/GB2018/051255 WO2019110951A1 (en) | 2017-12-04 | 2018-05-10 | Prevention and/or treatment of neurodegenerative disease |
| JP2020521460A JP7824729B2 (ja) | 2017-12-04 | 2018-05-10 | 神経変性疾患の予防及び／又は治療 |
| MX2020002458A MX2020002458A (es) | 2017-12-04 | 2018-05-10 | Prevencion y/o tratamiento de una enfermedad neurodegenerativa. |
| GB1807590.3A GB2568986B (en) | 2017-12-04 | 2018-05-10 | Prevention and/or treatment of neurodegenerative disease |
| NZ761512A NZ761512B2 (en) | 2018-05-10 | Prevention and/or treatment of neurodegenerative disease | |
| RU2020111305A RU2020111305A (ru) | 2017-12-04 | 2018-05-10 | Предупреждение и/или лечение нейродегенеративного заболевания |
| ES18725605T ES3047101T3 (en) | 2017-12-04 | 2018-05-10 | Prevention and/or treatment of neurodegenerative disease |
| BR112020005132-2A BR112020005132A2 (pt) | 2017-12-04 | 2018-05-10 | prevenção e/ou tratamento de doença neurodegenerativa |
| SG11202000786RA SG11202000786RA (en) | 2017-12-04 | 2018-05-10 | Prevention and/or treatment of neurodegenerative disease |
| IE20180146A IE87241B1 (en) | 2017-12-04 | 2018-05-15 | Prevention and/or treatment of neurodegenerative disease |
| US15/980,083 US10835509B2 (en) | 2017-12-04 | 2018-05-15 | Prevention and/or treatment of neurodegenerative disease |
| US16/426,771 US20190307715A1 (en) | 2017-12-04 | 2019-05-30 | Prevention and/or treatment of neurodegenerative disease |
| ZA2020/00558A ZA202000558B (en) | 2017-12-04 | 2020-01-28 | Prevention and/or treatment of neurodegenerative disease |
| JP2025184568A JP2026016698A (ja) | 2017-12-04 | 2025-10-31 | 神経変性疾患の予防及び／又は治療 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1720119.5A GB201720119D0 (en) | 2017-12-04 | 2017-12-04 | Prevention and/or treatment of neurodegenerative disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB201720119D0 true GB201720119D0 (en) | 2018-01-17 |
Family
ID=60950313
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB1720119.5A Ceased GB201720119D0 (en) | 2017-12-04 | 2017-12-04 | Prevention and/or treatment of neurodegenerative disease |
| GB1807590.3A Active GB2568986B (en) | 2017-12-04 | 2018-05-10 | Prevention and/or treatment of neurodegenerative disease |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1807590.3A Active GB2568986B (en) | 2017-12-04 | 2018-05-10 | Prevention and/or treatment of neurodegenerative disease |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US10835509B2 (https=) |
| EP (2) | EP3644979B1 (https=) |
| JP (2) | JP7824729B2 (https=) |
| KR (1) | KR20200095452A (https=) |
| AU (1) | AU2018379644B2 (https=) |
| BR (1) | BR112020005132A2 (https=) |
| CA (1) | CA3071786C (https=) |
| ES (1) | ES3047101T3 (https=) |
| GB (2) | GB201720119D0 (https=) |
| IE (1) | IE87241B1 (https=) |
| MX (1) | MX2020002458A (https=) |
| RU (1) | RU2020111305A (https=) |
| SG (1) | SG11202000786RA (https=) |
| WO (1) | WO2019110951A1 (https=) |
| ZA (1) | ZA202000558B (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3106957B1 (fr) * | 2020-02-07 | 2024-05-03 | Abdelhadi Zahouani | Composition alimentaire pour stimuler la fonction cognitive et prevenir et limiter le declin cognitif et la demence chez des sujets adultes ou chez des sujets ages denutris |
| US12076299B2 (en) * | 2020-02-20 | 2024-09-03 | Arjuna Natural Pvt Ltd | Composition and method to enhance cognitive support and brain health |
| KR20240008846A (ko) * | 2021-05-17 | 2024-01-19 | 오노 야꾸힝 고교 가부시키가이샤 | 인지 기능을 개선하기 위한 조성물 |
| JPWO2024143060A1 (https=) * | 2022-12-26 | 2024-07-04 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050163873A1 (en) | 2004-01-14 | 2005-07-28 | Robert Ritch | Methods and formulations for treating glaucoma |
| US8324276B2 (en) * | 2005-01-24 | 2012-12-04 | Pronova Biopharma Norge As | Fatty acid composition for treatment of alzheimer's disease and cognitive dysfunction |
| WO2006116755A2 (en) * | 2005-04-28 | 2006-11-02 | Trustees Of Tufts College | Synergitic effects of docosahexaenoic acid (dha) and carotenoid absorption of cognitive function |
| PL2219478T3 (pl) * | 2007-12-17 | 2017-10-31 | Newtricious Bv | Sposób wytwarzania funkcjonalnego produktu spożywczego na bazie żółtka jaja i produkty otrzymywane tym sposobem |
| GB201014340D0 (en) | 2010-08-27 | 2010-10-13 | Piraee Mahmood | Nutritional supplement formulation comprising saffron and resveratrol |
| HUE038813T2 (hu) * | 2011-07-07 | 2018-11-28 | Howard Foundation Holdings Ltd | Eljárás rontó káprázás javítására |
| DE212013000066U1 (de) * | 2012-07-19 | 2014-09-25 | U.S. Nutraceuticals Llc Dba Valensa International | Krillöl und reagierte Astaxanthinzusammensetzung |
| GB201300055D0 (en) | 2013-01-03 | 2013-02-20 | Howard Foundation Holdings Ltd | Identifying subjects in need of treatment |
| US20140187648A1 (en) * | 2013-01-03 | 2014-07-03 | Howard Foundation Holdings Ltd. | Identifying Subjects in Need of Treatment |
| MX2015013624A (es) * | 2013-03-28 | 2016-06-10 | Omniactive Health Technologies Ltd | Efecto neuroprotector de carotenoides en el cerebro. |
| JP6178761B2 (ja) | 2013-07-10 | 2017-08-09 | ライオン株式会社 | 内服剤 |
| US20190314442A1 (en) * | 2016-02-22 | 2019-10-17 | Newtricious B.V. | Composition for the prevention or treatment of neurodegenerative diseases |
-
2017
- 2017-12-04 GB GBGB1720119.5A patent/GB201720119D0/en not_active Ceased
-
2018
- 2018-05-10 MX MX2020002458A patent/MX2020002458A/es unknown
- 2018-05-10 CA CA3071786A patent/CA3071786C/en active Active
- 2018-05-10 ES ES18725605T patent/ES3047101T3/es active Active
- 2018-05-10 AU AU2018379644A patent/AU2018379644B2/en active Active
- 2018-05-10 SG SG11202000786RA patent/SG11202000786RA/en unknown
- 2018-05-10 RU RU2020111305A patent/RU2020111305A/ru unknown
- 2018-05-10 BR BR112020005132-2A patent/BR112020005132A2/pt not_active Application Discontinuation
- 2018-05-10 KR KR1020207007980A patent/KR20200095452A/ko active Pending
- 2018-05-10 GB GB1807590.3A patent/GB2568986B/en active Active
- 2018-05-10 EP EP18725605.2A patent/EP3644979B1/en active Active
- 2018-05-10 JP JP2020521460A patent/JP7824729B2/ja active Active
- 2018-05-10 WO PCT/GB2018/051255 patent/WO2019110951A1/en not_active Ceased
- 2018-05-10 EP EP25186112.6A patent/EP4599891A3/en active Pending
- 2018-05-15 IE IE20180146A patent/IE87241B1/en unknown
- 2018-05-15 US US15/980,083 patent/US10835509B2/en active Active
-
2020
- 2020-01-28 ZA ZA2020/00558A patent/ZA202000558B/en unknown
-
2025
- 2025-10-31 JP JP2025184568A patent/JP2026016698A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| GB2568986A (en) | 2019-06-05 |
| IE20180146A1 (en) | 2019-06-12 |
| MX2020002458A (es) | 2020-07-20 |
| CA3071786A1 (en) | 2019-06-13 |
| EP3644979A1 (en) | 2020-05-06 |
| EP4599891A3 (en) | 2025-10-22 |
| SG11202000786RA (en) | 2020-06-29 |
| AU2018379644A1 (en) | 2020-03-19 |
| NZ761512A (en) | 2024-01-26 |
| WO2019110951A1 (en) | 2019-06-13 |
| GB2568986B (en) | 2019-12-18 |
| AU2018379644B2 (en) | 2024-02-08 |
| CA3071786C (en) | 2023-11-14 |
| ES3047101T3 (en) | 2025-12-03 |
| ZA202000558B (en) | 2021-10-27 |
| RU2020111305A (ru) | 2022-01-10 |
| JP2026016698A (ja) | 2026-02-03 |
| EP4599891A2 (en) | 2025-08-13 |
| EP3644979B1 (en) | 2025-08-06 |
| US20190167624A1 (en) | 2019-06-06 |
| GB201807590D0 (en) | 2018-06-27 |
| JP2021505527A (ja) | 2021-02-18 |
| JP7824729B2 (ja) | 2026-03-05 |
| US10835509B2 (en) | 2020-11-17 |
| KR20200095452A (ko) | 2020-08-10 |
| BR112020005132A2 (pt) | 2020-09-15 |
| IE87241B1 (en) | 2021-07-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL277648A (en) | Medical microbiota for the treatment and/or prevention of food allergy | |
| ZA201908165B (en) | Compounds for the prevention and treatment of diseases and the use thereof | |
| ZA201901055B (en) | Treatment and prevention of sleep disorders | |
| IL272097A (en) | Compounds for the prevention and treatment of medical disorders and their uses | |
| IL281585B (en) | Selenogalactoside compounds for the prevention and treatment of galectin-related diseases and their use | |
| EP3694523A4 (en) | METHODS AND SUBSTANCES FOR PREVENTION AND TREATMENT OF NEURODEGENERATIVE DISEASES | |
| ZA202000558B (en) | Prevention and/or treatment of neurodegenerative disease | |
| IL274588A (en) | Methods and preparations for improving lysosome function and treating neurodegenerative disease | |
| PT3558335T (pt) | Inibição da caspase-1 e sua utilização na prevenção e tratamento de doenças neurológicas | |
| SG11201705889VA (en) | Prevention or Treatment of Uratic or Gouty Diseases | |
| GB201714307D0 (en) | Treatment of neurodegenerative diseases | |
| GB201616009D0 (en) | Treatment and/or prevention of sepsis | |
| SG11201704430SA (en) | Preventive and/or therapeutic agent of immune disease | |
| PL3137097T3 (pl) | Leczenie i profilaktyka choroby Alzheimera (AD) | |
| SI3197556T1 (sl) | Sestavek za preprečevanje in/ali zdravljenje alergijskih simptomov | |
| ZA201906964B (en) | Prevention and/or treatment of inflammatory skin disease | |
| GB201615298D0 (en) | Treatment and prevention of Malaria | |
| GB201522329D0 (en) | Use of adjuvants for the prevention and/or treatment of autoimmune diseases | |
| PL3137094T3 (pl) | Leczenie i profilaktyka choroby alzheimera (ad) | |
| IL259383A (en) | A compound for use in the prevention and treatment of neurodegenerative diseases | |
| LT3137093T (lt) | Alzheimerio ligos (ad) gydymas ir prevencija | |
| GB201719969D0 (en) | Prevention and/or treatment of neurodegenerative disease | |
| GB201714311D0 (en) | Treatment of neurodegenerative diseases | |
| GB201714303D0 (en) | Treatment of neurodegenerative diseases | |
| PL3490604T3 (pl) | Środek leczniczy do leczenia i/lub zapobiegania endometriozie |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |